Low Dose Exposure to Di-2-Ethylhexylphthalate in Juvenile Rats Alters the Expression of Genes Related with Thyroid Hormone Regulation.
10.4062/biomolther.2018.076
- Author:
Minjeong KIM
1
;
Ji Seong JEONG
;
Hyunji KIM
;
Seungwoo HWANG
;
Il Hyun PARK
;
Byung Chul LEE
;
Sung Il YOON
;
Sun Ha JEE
;
Ki Taek NAM
;
Kyung Min LIM
Author Information
1. College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea. kmlim@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Phthalate;
di-2-ethylhexylphthalate (DEHP);
Thyroid;
Juvenile toxicity;
Thyroid hormone;
Proliferation
- MeSH:
Animals;
Diethylhexyl Phthalate*;
Female;
Humans;
Hyperplasia;
Male;
Parathyroid Hormone;
Plastics;
Rats*;
RNA, Messenger;
Thyroglobulin;
Thyroid Gland*;
Thyrotropin-Releasing Hormone;
Weaning
- From:Biomolecules & Therapeutics
2018;26(5):512-519
- CountryRepublic of Korea
- Language:English
-
Abstract:
Phthalates widely used in the manufacture of plastics have deeply penetrated into our everyday lives. Recently, a concern over the toxicity of phthalates on thyroid, has been raised but in most of cases, the doses employed were unrealistically high. To investigate the effects of phthalates on thyroid, we investigated the effects of the repeated oral exposure to low to high doses (0.3, 3, 30 and 150 mg/kg) di-2-ethylhexylphthalate (DEHP) from weaning to maturity for 90 days in juvenile rats on the thyroid. The histological examination revealed that DEHP significantly induced hyperplasia in the thyroid from the doses of 30 mg/kg, which was confirmed with Ki67 staining. In line with this finding, increased mRNA expression of thyrotropin releasing hormone (Trh) was observed in the thyroid of female at 0.3 mg/kg and 150 mg/kg as determined by RNAseq analysis. Moreover, significantly increased expression of parathyroid hormone (Pth) in the female at 0.3 mg/kg, and thyroglobulin (Tg) and thyroid hormone responsive (Thrsp) in the male at 0.3 mg/kg were noted in the blood, of which changes were substantially attenuated at 150 m/kg, alluding the meaningful effects of low dose DEHP on the thyroid hormone regulation. Urinary excretion of mono-2-ethylhexyl-phthalate (MEHP), a major metabolite of DEHP was determined to be 4.10 and 12.26 ppb in male, 6.65 and 324 ppb in female at 0.3 and 30 mg/kg DEHP, respectively, which fell within reported human urine levels. Collectively, these results suggest a potential adverse effects of low dose phthalates on the thyroid.
